Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease.
Ellis SG, Kereiakes DJ, Metzger DC, Caputo RP, Rizik DG, Teirstein PS, Litt MR, Kini A, Kabour A, Marx SO, Popma JJ, McGreevy R, Zhang Z, Simonton C, Stone GW; ABSORB III Investigators. Ellis SG, et al. Among authors: teirstein ps. N Engl J Med. 2015 Nov 12;373(20):1905-15. doi: 10.1056/NEJMoa1509038. Epub 2015 Oct 12. N Engl J Med. 2015. PMID: 26457558 Free article. Clinical Trial.
Effect of catheter-based iridium-192 gamma brachytherapy on the added risk of restenosis from diabetes mellitus after intervention for in-stent restenosis (subanalysis of the GAMMA I Randomized Trial).
Moses JW, Moussa I, Leon MB, Teirstein PS, Fish RD, Ellis SG, Nawas D, Kluck B, Giorgianni JA, Donohoe D, Kuntz RE. Moses JW, et al. Among authors: teirstein ps. Am J Cardiol. 2002 Aug 1;90(3):243-7. doi: 10.1016/s0002-9149(02)02462-1. Am J Cardiol. 2002. PMID: 12127611 Clinical Trial.
Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis.
Popma JJ, Suntharalingam M, Lansky AJ, Heuser RR, Speiser B, Teirstein PS, Massullo V, Bass T, Henderson R, Silber S, von Rottkay P, Bonan R, Ho KK, Osattin A, Kuntz RE; Stents And Radiation Therapy (START) Investigators. Popma JJ, et al. Among authors: teirstein ps. Circulation. 2002 Aug 27;106(9):1090-6. doi: 10.1161/01.cir.0000027814.96651.72. Circulation. 2002. PMID: 12196334 Clinical Trial.
Long-term outcome of patients treated with repeat percutaneous coronary intervention after failure of gamma-brachytherapy for the treatment of in-stent restenosis.
Prpic R, Teirstein PS, Reilly JP, Moses JW, Tripuraneni P, Lansky AJ, Giorgianni JA, Jani S, Wong SC, Fish RD, Ellis S, Holmes DR, Kereiakas D, Kuntz RE, Leon MB. Prpic R, et al. Among authors: teirstein ps. Circulation. 2002 Oct 29;106(18):2340-5. doi: 10.1161/01.cir.0000036366.62288.74. Circulation. 2002. PMID: 12403664
Implications of the presence and length of "geographic miss" on restenosis and the edge phenomenon in the INHIBIT trial.
Costantini CO, Lansky AJ, Mintz GS, Shirai K, Teirstein PS, Stone G, Vandertie L, Proctor B, Fahy M, Yeung A, Raizner AE, Waksman R, Leon MB; INHIBIT trial. Costantini CO, et al. Among authors: teirstein ps. Am J Cardiol. 2003 May 15;91(10):1261-5. doi: 10.1016/s0002-9149(03)00280-7. Am J Cardiol. 2003. PMID: 12745117 Clinical Trial. No abstract available.
Intravascular brachytherapy for native coronary ostial in-stent restenotic lesions.
Costantini CO, Lansky AJ, Mintz GS, Shirai K, Dangas G, Mehran R, Fahy M, Slack S, Coral M, Teirstein PS, Waksman R, Stone G, Moses J, Leon MB. Costantini CO, et al. Among authors: teirstein ps. J Am Coll Cardiol. 2003 May 21;41(10):1725-31. doi: 10.1016/s0735-1097(03)00298-5. J Am Coll Cardiol. 2003. PMID: 12767655 Free article. Clinical Trial.
197 results